180 related articles for article (PubMed ID: 26759305)
1. The human RNA surveillance factor UPF1 regulates tumorigenesis by targeting Smad7 in hepatocellular carcinoma.
Chang L; Li C; Guo T; Wang H; Ma W; Yuan Y; Liu Q; Ye Q; Liu Z
J Exp Clin Cancer Res; 2016 Jan; 35():8. PubMed ID: 26759305
[TBL] [Abstract][Full Text] [Related]
2. The C/D box small nucleolar RNA SNORD52 regulated by Upf1 facilitates Hepatocarcinogenesis by stabilizing CDK1.
Li C; Wu L; Liu P; Li K; Zhang Z; He Y; Liu Q; Jiang P; Yang Z; Liu Z; Yuan Y; Chang L
Theranostics; 2020; 10(20):9348-9363. PubMed ID: 32802196
[No Abstract] [Full Text] [Related]
3. UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1.
Zhou Y; Li Y; Wang N; Li X; Zheng J; Ge L
Sci Rep; 2019 Apr; 9(1):6652. PubMed ID: 31040354
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma.
Chang L; Yuan Y; Li C; Guo T; Qi H; Xiao Y; Dong X; Liu Z; Liu Q
Cancer Lett; 2016 Dec; 383(2):183-194. PubMed ID: 27702662
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA SNAI3-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma by regulating the UPF1/Smad7 signalling pathway.
Li Y; Guo D; Ren M; Zhao Y; Wang X; Chen Y; Liu Y; Lu G; He S
J Cell Mol Med; 2019 Sep; 23(9):6271-6282. PubMed ID: 31264769
[TBL] [Abstract][Full Text] [Related]
6. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
[TBL] [Abstract][Full Text] [Related]
7. Effects of UPF1 expression on EMT process by targeting E‑cadherin, N‑cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line.
Li Y; Zhang T; Qin S; Wang R; Li Y; Zhou Z; Chen Y; Wu Q; Su F
Mol Med Rep; 2019 Mar; 19(3):2137-2143. PubMed ID: 30628676
[TBL] [Abstract][Full Text] [Related]
8. Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
Feng T; Dzieran J; Gu X; Marhenke S; Vogel A; Machida K; Weiss TS; Ruemmele P; Kollmar O; Hoffmann P; Grässer F; Allgayer H; Fabian J; Weng HL; Teufel A; Maass T; Meyer C; Lehmann U; Zhu C; Mertens PR; Gao CF; Dooley S; Meindl-Beinker NM
Clin Sci (Lond); 2015 Jun; 128(11):761-74. PubMed ID: 25602745
[TBL] [Abstract][Full Text] [Related]
9. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
10. The human RNA surveillance factor Up-frameshift 1 inhibits hepatic cancer progression by targeting MRP2/ABCC2.
Zhang H; You Y; Zhu Z
Biomed Pharmacother; 2017 Aug; 92():365-372. PubMed ID: 28554132
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ
Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897
[TBL] [Abstract][Full Text] [Related]
12. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
Wu WR; Sun H; Zhang R; Yu XH; Shi XD; Zhu MS; Zeng H; Yan LX; Xu LB; Liu C
Oncotarget; 2016 Apr; 7(14):18684-93. PubMed ID: 26919246
[TBL] [Abstract][Full Text] [Related]
13. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract][Full Text] [Related]
16. ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function.
Sun N; Zhong X; Wang S; Zeng K; Sun H; Sun G; Zou R; Liu W; Liu W; Lin L; Song H; Lv C; Wang C; Zhao Y
EBioMedicine; 2020 Dec; 62():103108. PubMed ID: 33186807
[TBL] [Abstract][Full Text] [Related]
17. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
18. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.
Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP
Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1.
Ding LJ; Li Y; Wang SD; Wang XS; Fang F; Wang WY; Lv P; Zhao DH; Wei F; Qi L
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669232
[TBL] [Abstract][Full Text] [Related]
20. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
